BAM
XBI icon

Belpointe Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,393
Closed -$1.05M 1045
2024
Q4
$1.05M Buy
10,393
+92
+0.9% +$9.32K 0.06% 301
2024
Q3
$1.02M Sell
10,301
-1,081
-9% -$107K 0.06% 311
2024
Q2
$1.06M Buy
11,382
+2,672
+31% +$248K 0.07% 257
2024
Q1
$826K Sell
8,710
-5,214
-37% -$495K 0.06% 318
2023
Q4
$1.24M Buy
13,924
+9,586
+221% +$856K 0.11% 184
2023
Q3
$317K Sell
4,338
-6,099
-58% -$445K 0.03% 455
2023
Q2
$868K Buy
10,437
+883
+9% +$73.5K 0.09% 211
2023
Q1
$728K Sell
9,554
-882
-8% -$67.2K 0.04% 420
2022
Q4
$866K Sell
10,436
-2,335
-18% -$194K 0.05% 361
2022
Q3
$1.01M Buy
12,771
+1,553
+14% +$123K 0.07% 289
2022
Q2
$834K Buy
11,218
+6,240
+125% +$464K 0.06% 343
2022
Q1
$448K Sell
4,978
-511
-9% -$46K 0.03% 573
2021
Q4
$614K Sell
5,489
-120
-2% -$13.4K 0.04% 459
2021
Q3
$705K Buy
5,609
+1,297
+30% +$163K 0.05% 407
2021
Q2
$584K Sell
4,312
-14,207
-77% -$1.92M 0.04% 449
2021
Q1
$2.51M Sell
18,519
-1,191
-6% -$162K 0.22% 94
2020
Q4
$2.78M Sell
19,710
-5,238
-21% -$737K 0.25% 84
2020
Q3
$2.78M Sell
24,948
-5,466
-18% -$609K 0.31% 66
2020
Q2
$3.41M Buy
30,414
+13,189
+77% +$1.48M 0.44% 43
2020
Q1
$1.33M Sell
17,225
-10,412
-38% -$806K 0.23% 101
2019
Q4
$2.63M Buy
27,637
+23,248
+530% +$2.21M 0.33% 75
2019
Q3
$335K Sell
4,389
-17,754
-80% -$1.36M 0.05% 367
2019
Q2
$1.94M Buy
+22,143
New +$1.94M 0.38% 52
2019
Q1
Sell
-4,125
Closed -$296K 593
2018
Q4
$296K Sell
4,125
-33,025
-89% -$2.37M 0.08% 281
2018
Q3
$3.56M Sell
37,150
-698
-2% -$66.9K 0.56% 26
2018
Q2
$3.6M Buy
+37,848
New +$3.6M 1.01% 11
2018
Q1
Sell
-2,756
Closed -$234K 494
2017
Q4
$234K Buy
+2,756
New +$234K 0.05% 390